Showing results (221-230 of 236) with videos related to
Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancerR Komaki, D M Shin, B S Glisson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RDJoel Pekow, Katherine Meckel, Urszula Dougherty, et al.Annals of Surgical Oncology|September 1, 1994
Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantationN A Janjan, A W Yasko, G P Reece, et al.International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and largerScott R Floyd, Thomas A Buchholz, Bruce G Haffty, et al.Journal of Crohn'S & Colitis|February 13, 2019
IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon CancersJoel Pekow, Kyle Hernandez, Katherine Meckel, et al.Clinical and Translational Science|November 24, 2025
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel DiseaseNikhil Reddy, Jeremy A Klein, Nikita Thomas, et al.Cureus|December 28, 2023
Knowledge, Attitude, and Practices Regarding the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome Among Primary Healthcare Physicians in Saudi ArabiaTahani A Khalil, Doaa Mohammad Filmban, Hussam Nasser M Sinnah, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2016
ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon CancerReba Mustafi, Urszula Dougherty, Devkumar Mustafi, et al.Scientific Reports|March 19, 2021
Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune modelJatin Sharma, Teresa D Collins, Tracoyia Roach, et al.British Journal of Cancer|November 27, 2001
Routine breast screening for women aged 65-69: results from evaluation of the demonstration sitesS M Moss, J Brown, L Garvican, et al.Pageof 24